EP1379557 - Bibliographic data

USE OF CD25 BINDING MOLECULES IN STEROID-RESISTANT PATIENTS

Last update 13/07/2025
Legal status Brevet déchu
Origin Euro-PCT
(73) Holder

UNIVERSITY OF BRISTOL

3rd Floor, Senate House, Tyndall Avenue
Bristol BS8 1TH
Royaume-Uni
(72) Inventors

HEARING, Stephen David

1 Joules Drive
Stone, Staffordshire ST15 8ZS
Royaume-Uni

DAYAN, Colin Mark

18 Highbury Villas
Bristol BS2 8BX
Royaume-Uni

NORMAN, Michael Roden

31 Fremantle Road, Cotham
Bristol BS6 5SX
Royaume-Uni
(74) Agent

Mail recipient

NASH, DAVID ALLAN

Haseltine Lake LLP Redcliff Quay 120 Redcliff Street
WC2B 6UD
LONDON
Royaume-Uni
(21) Request number EP02740446.6
(22) Request date 05/04/2002
(11) Publication number EP1379557
Publication date 17/09/2008
(54) Title of the invention USE OF CD25 BINDING MOLECULES IN STEROID-RESISTANT PATIENTS
(51) International classification C07K 16/28
International classification (before reform) None
Claimed priority

(31) Number: 0108821
(32) Date: 06/04/2001
(33) Country: GB

(31) Number: 0108817
(32) Date: 06/04/2001
(33) Country: GB

(31) Number: 0108816
(32) Date: 06/04/2001
(33) Country: GB

Initial application None
Divisional application None
Expected annuity Annuity: 8 - Amount: 105 € - Due date 30/04/2009
Surtax: 8 - Amount: 21 € - Due date 02/11/2009
Last annuity None
Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2008/3, of 30/09/2008

History

Publication de la délivrance du brevet européen - Legal date 17/09/2008

Déchéance du brevet d'invention après période de grâce - Legal date 30/04/2009

Entrée en période de grâce du brevet d'invention - Legal date 30/04/2009